MyAverix Finance
NS · Pharmaceuticals
Sun Pharma Advanced Research Company Ltd (SPARC)
Pharmaceuticals & Biotechnology
Sun Pharma Advanced Research Company Ltd (SPARC) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $76.10B, P/E ratio is 4.90, net margin is -252.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SPARC
Sun Pharma Advanced Research Company Ltd (SPARC) — FAQ
What is Sun Pharma Advanced Research Company Ltd's market cap?
Sun Pharma Advanced Research Company Ltd (SPARC) has a reported market cap of $76.10B (data as of 2026-07-10).
What is SPARC's P/E ratio?
The price-to-earnings (P/E) ratio for Sun Pharma Advanced Research Company Ltd (SPARC) is 4.90 (data as of 2026-07-10).
Does Sun Pharma Advanced Research Company Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Sun Pharma Advanced Research Company Ltd (SPARC). Check the MyAverix Finance app for the latest dividend data.
What sector is Sun Pharma Advanced Research Company Ltd in?
Sun Pharma Advanced Research Company Ltd (SPARC) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is SPARC listed on?
SPARC is listed on NS.
What is Sun Pharma Advanced Research Company Ltd's net margin?
Sun Pharma Advanced Research Company Ltd (SPARC) reports a net margin of -252.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.